Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202106014 | Trifluoperazine hydrochlorid 2mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215039012 | Trifluoperazine hydrochlorid 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2463821016 | Trifluoperazine hydrochloride 2mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2470303012 | Trifluoperazine hydrochloride 2mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3472279015 | Product containing trifluoperazine hydrochloride 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490308010 | Product containing trifluoperazine hydrochloride 2 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501526010 | Trifluoperazine hydrochloride 2 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3568944010 | Product containing only trifluoperazine hydrochloride 2 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568945011 | Product containing only trifluoperazine hydrochloride 2 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683809016 | Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683810014 | Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Is a | Product containing trifluoperazine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Is a | Product containing trifluoperazine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has active ingredient | Trifluoperazine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Is a | Trifluoperazine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has active ingredient | Trifluoperazine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has active ingredient | Trifluoperazine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has basis of strength substance | Trifluoperazine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has precise active ingredient | Trifluoperazine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely trifluoperazine hydrochloride 2 milligram/1 each conventional release oral tablet | Is a | Product containing only trifluoperazine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR